Acute in vivo exposure to ethylcholine aziridinium (AF64A) depresses the secretion of quanta from motor nerve terminals.

[1]  H. Yamamura,et al.  Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system. , 1985, The Journal of pharmacology and experimental therapeutics.

[2]  D. McKeag,et al.  Intracerebroventricular administration of ethylcholine mustard aziridinium ion (AF64A) reduces release of acetylcholine from rat hippocampal slices , 1985, Neuropharmacology.

[3]  D. McKeag,et al.  AF64A (ethylcholine mustard aziridinium) in vivo: Time course of cholinotoxicity , 1985 .

[4]  I. Hanin,et al.  AF64A Cholinotoxicity: Functional Aspects , 1985 .

[5]  T. J. Walsh,et al.  AF64A, a cholinergic neurotoxin, selectively depletes acetylcholine in hippocampus and cortex, and produces long-term passive avoidance and radial-arm maze deficits in the rat , 1984, Brain Research.

[6]  A. Fisher,et al.  Possible mechanisms involved in the presynaptic cholinotoxicity due to ethylcholine aziridinium (AF64A) in vivo. , 1984, Life sciences.

[7]  A. Fisher,et al.  Selective inhibition of peripheral cholinergic transmission in the cat produced by AF64A. , 1983, The Journal of pharmacology and experimental therapeutics.

[8]  M. Zigmond,et al.  Selective Presynaptic Cholinergic Neurotoxicity Following Intrahippocampal AF64A Injection in Rats , 1983, Journal of neurochemistry.

[9]  D. Abraham,et al.  Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. , 1982, The Journal of pharmacology and experimental therapeutics.